William Chase on Abbott's M&A strategy - The Deal Pipeline (SAMPLE CONTENT: NEED AN ID?)
Subscriber Content Preview | Request a free trialSearch  
  Go

Video

Share  |  Reprint

William Chase on Abbott's M&A strategy

Published November 19, 2012 at 1:04 PM


William Chase, Abbott Laboratories' vice president of licensing and acquisitions, and The Deal Pipeline's Ben Fidler discuss the pharmaceutical giant's acquisition strategy as it prepares to split into two different companies at the start of 2013. - George White

Share:

Meet the journalists



Movers & Shakers

Launch Movers and shakers slideshow

Jeremy C. Stein, a former member of the Board of Governors of the Federal Reserve System, will consult hedge fund BlueMountain Capital Management LLC. For other updates launch today's Movers & shakers slideshow.

Video

David Marcus and Rob Kindler discuss the outlook for M&A in 2015

Rob Kindler, the global head of M&A and vice chairman at Morgan Stanley, says that the M&A market remains strong, continuing trends from last year. More video

Sectors